Search
for
Sort by
Research 691–720 of 1000+
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Determinants of Occipital Involvement in Males and Females with Pattern Hair Loss: A Retrospective Study
- Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients
- Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Utility of trichoscopy in comparison to the standard methods for assessing the disease activity, severity, and therapeutic response in alopecia areata
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- 165 Single-cell RNA sequencing analysis unveils highly active yet diminished CD14+CD16- circulating monocytes, independent of alopecia areata severity
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- BH08 Evaluating quality-of-life measures for alopecia: a comparative analysis of Dermatology Life Quality Index and Hospital Anxiety and Depression Scale correlations with disease severity
- Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches
- Assessment of clinician-reported outcome measures for alopecia areata: a systematic scoping review
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Quality of Life in Alopecia Areata: A Study of 60 Cases
- Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea
- Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Dermoscopic findings of alopecia areata in dark skinned individuals: An analysis of 116 cases
- Rethinking the classification of alopecia areata
- Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Signposts to the Promised Land in Alopecia Areata
- Alopecia areata and vitamin D: Is there any association?